Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent &lt;i&gt;Clostridioides difficile&lt;/i&gt; Infection Patients for Fecal Microbiota Transplant: A Retrospective Cohort Analysis

Bacterial Infections

Customised infectiology - Fecal microbiota transplantation: following the Clostridioides difficile pathway

Rev Med Suisse.

Galperine TK, Guery B

SPECIAL REPORT

HIV / AIDS

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021

Bacterial Infections

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

Clin Microbiol Infect

van Prehn J, Reigadas E, Vogelzang EH, Bouza E, Hristea A, Guery B, Krutova M, Norén T, Allerberger F, Coia J, Goorhuis A, van Rossen TM, Ooijevaar RE, Burns K, Scharvik Olesen BR, Tschudin-Sutter S, Wilcox MH, Vehreschild M, Fitzpatrick F, Kuijper EJ, guideline committee of the European Study Group on Clostridioides difficile.

doi: 10.1016/j.cmi.2021.09.038

Fungal Infections

Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study

Lancet Infect Dis.

Mejia-Chew C, O'Halloran JA, Olsen MA, Stwalley D, Kronen R, Lin C, Salazar AS, Larson L, Hsueh K, Powderly WG, Spec A

doi: 10.1016/S1473-3099(19)30405-0.

Bacterial Infections

Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile Infection

doi: 10.1093/cid/ciz809.

Bacterial Infections

Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study

Clin Microbiol Infect.

Giannella M, Pascale R, Pancaldi L, Monari C, Ianniruberto S, Malosso P, Bussini L, Bartoletti M, Tedeschi S, Ambretti S, Lewis R, Viale P

doi: 10.1016/j.cmi.2020.01.023.

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

Lancet Infect Dis.

Guery B, Menichetti F, Anttila VJ, Adomakoh N, Aguado JM, Bisnauthsing K, Georgopali A, Goldenberg SD, Karas A, Kazeem G, Longshaw C, Palacios-Fabrega JA, Cornely OA, Vehreschild MJGT; EXTEND Clinical Study Group

doi: 10.1016/

Bacterial Infections

Predictors of Clostridioidesdifficile Infection among Asymptomatic Colonized Patients: A Retrospective Cohort Study

Clin Infect Dis.

Poirier D, Gervais P, Fuchs M, Roussy JF, Paquet-Bolduc B, Trottier S, Longtin J, Loo VG, Longtin Y

doi: 10.1093/cid/ciz626.

Bacterial Infections

Safety and efficacy of fidaxomicin and vancomycin in children and adolescents with Clostridioides (Clostridium) difficile infection: a phase 3, multicenter, randomized, single-blind clinical trial (SUNSHINE)

Clin Infect Dis.

Wolf J, Kalocsai K, Fortuny C, Lazar S, Bosis S, Korczowski B, Petit A, Bradford D, Croos-Dabrera R, Incera E, Melis J, van Maanen R

doi: 10.1093/cid/ciz1149.

Infectiology · Anesthesiology · Pain

Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent <i>Clostridioides difficile</i> Infection Patients for Fecal Microbiota Transplant: A Retrospective Cohort Analysis

Related content

Customised infectiology - Fecal microbiota transplantation: following the Clostridioides difficile pathway

11e Conférence de la Société internationale sur le SIDA (IAS) 2021

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study

Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile Infection

Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

Predictors of Clostridioidesdifficile Infection among Asymptomatic Colonized Patients: A Retrospective Cohort Study

Safety and efficacy of fidaxomicin and vancomycin in children and adolescents with Clostridioides (Clostridium) difficile infection: a phase 3, multicenter, randomized, single-blind clinical trial (SUNSHINE)

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021